Enabling the Future of Medicine
WuXi Advanced Therapies is a Contract Testing, Development and Manufacturing Organization (CTDMO). We offer technology platforms and services that enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support patients around the world.
Awards & Recognition
2024
Included in S&P Global Sustainability Yearbook 2024
2023
Frost & Sullivan 2023 Global CDRMO Company of the Year
2023
EcoVadis Silver Medal for Sustainability Achievement
2023
Phacilitate Advanced Therapies Awards - Manufacturing Tech Disruptor of the Year
Our Role in the Industry
WuXi Advanced Therapies works with hundreds of companies to help them research, discover, test, develop, and manufacture advanced therapeutics that benefit patients. We have always been guided by our core value of “doing the right thing and doing it right.” And we remain committed to this ethos in everything we do.
Our Mission
The mission for WuXi Advanced Therapies is to help make safe and effective cell and gene therapies available to patients quickly and efficiently. Our role is to work alongside therapy developers to help them research, discover, analyze, test, develop, and manufacture products that provide an alternative approach to traditional pharmaceutical approaches.
Privacy, Security and Intellectual Property
One of our core business tenets is to ensure and preserve the trust, confidence, and privacy of our customers. We know how integral the intellectual property (IP) that you develop is to your success and competitiveness and safeguarding it has always been of the utmost importance to our company. We have a strong security infrastructure and robust corporate culture that protects the intellectual property and data of our customers and their patients.
Environmental, Social and Governance
As a responsible business, we serve the long-term interest of our stakeholders. Our governance models include a Board of Directors and both a compliance department and audit committee. We strive to protect our planet with established targets for reduction in green-house gas (GHG), energy, and water consumption. We take our social responsibilities seriously and support patient advocacy groups like the Emily Whitehead and Opie Jones Foundations. Furthermore, we also prioritize employee development and diversity and inclusion in the workplace.
Tomorrow’s Therapies Need Today’s Talent
We hire top talent for a variety of positions that contribute to our success and the success of our partners. Our belief that our industry represents the future of medicine is evident in our hiring process. Our team is looking for professionals who share our passion for the industry and our commitment to making a positive impact on the lives of the patients we serve.
View Open PositionsArticles & Events
Five Best Practices to Adapt and Improve Quality Control Programs for CGTs
To launch a successful GMP program for biologics, a robust quality control (QC) release testing protocol is essential. QC testing, which is mandated by global regulatory authorities, helps ensure that a product meets scientific specifications and reaches patients safely. Though each program will have unique parameters, QC testing should gather data to answer the following questions:
Get in Touch with Us
Our team of experts is available to talk to you about your program's needs, critical milestones and timelines. You can also contact us to learn about career opportunities and more.
Need help with a project?
Testing, Development, Manufacturing.
All other inquiries
Human Resources, Procurement, Accounting.